Published in J Clin Microbiol on April 01, 1987
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Microbiol (1993) 2.94
Comparison of PCR-ribotyping, arbitrarily primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol (2000) 2.79
Genotypical variation of Campylobacter pylori from gastric mucosa. J Clin Microbiol (1990) 2.55
Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol (2006) 2.52
Use of plasmid profiles in epidemiologic surveillance of disease outbreaks and in tracing the transmission of antibiotic resistance. Clin Microbiol Rev (1988) 2.35
Restriction endonuclease analysis of Staphylococcus epidermidis DNA may be a useful epidemiological marker. J Clin Microbiol (1988) 2.27
Comparison of restriction endonuclease analysis, ribotyping, and pulsed-field gel electrophoresis for molecular differentiation of Clostridium difficile strains. J Clin Microbiol (1994) 2.23
Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol (2008) 2.17
Relapse versus reinfection with Clostridium difficile. Epidemiol Infect (1991) 1.69
Comparison of methods for discrimination between strains of Listeria monocytogenes from epidemiological surveys. Appl Environ Microbiol (1991) 1.69
Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol (2011) 1.65
Use of arbitrary primer PCR to type Clostridium difficile and comparison of results with those by immunoblot typing. J Clin Microbiol (1994) 1.63
Evaluation of restriction endonuclease fingerprinting of chromosomal DNA and plasmid profile analysis for characterization of multiresistant coagulase-negative staphylococci in bacteremic neonates. J Clin Microbiol (1990) 1.60
Determination of the epidemiology and transmission of nontypable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints. Infect Immun (1989) 1.57
Restriction endonuclease DNA analysis of Clostridium difficile. J Clin Microbiol (1987) 1.33
A molecular characterization of Clostridium difficile isolates from humans, animals and their environments. Epidemiol Infect (1993) 1.28
Characterization of flagella of Clostridium difficile and their role in serogrouping reactions. J Clin Microbiol (1990) 1.26
Phenotypic and genotypic diversity of the flagellin gene (fliC) among Clostridium difficile isolates from different serogroups. J Clin Microbiol (2000) 1.18
Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping. J Clin Microbiol (1993) 1.12
Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions. J Clin Microbiol (1988) 1.07
Clostridium difficile genotyping based on slpA variable region in S-layer gene sequence: an alternative to serotyping. J Clin Microbiol (2002) 1.01
Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping. Infect Control Hosp Epidemiol (2013) 0.94
Comparison of media for screening of diarrheic stools for the recovery of Clostridium difficile. J Clin Microbiol (1989) 0.91
Challenges for standardization of Clostridium difficile typing methods. J Clin Microbiol (2013) 0.88
Analysis of southern Ontario Actinobacillus (Haemophilus) pleuropneumoniae isolates by restriction endonuclease fingerprinting. Can J Vet Res (1990) 0.86
Investigation of an outbreak of Clostridium difficile infection in a general hospital by numerical analysis of protein patterns by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. J Clin Microbiol (1994) 0.80
DNA microarray-based PCR ribotyping of Clostridium difficile. J Clin Microbiol (2014) 0.75
Identification of outbreak-associated and other strains of Clostridium difficile by numerical analysis of SDS-PAGE protein patterns. Epidemiol Infect (1994) 0.75
Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet (1978) 11.99
Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis (1981) 3.76
Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med (1986) 3.06
Antibiotic-associated pseudomembranous colitis. Rev Infect Dis (1980) 3.02
Bacteriophage and bacteriocin typing scheme for Clostridium difficile. J Clin Microbiol (1983) 2.97
Typing scheme for Clostridium difficile: its application in clinical and epidemiological studies. Lancet (1984) 2.87
The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis (1986) 2.61
Is pseudomembranous colitis infectious? Lancet (1981) 2.34
Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am J Med (1981) 2.08
Immunochemical fingerprinting of Clostridium difficile strains isolated from an outbreak of antibiotic-associated colitis and diarrhoea. J Med Microbiol (1984) 2.07
Isolation of Clostridium difficile from patients and the environment of hospital wards. J Clin Pathol (1983) 1.89
Is Clostridium difficile endemic in chronic-care facilities? Lancet (1986) 1.88
Polyacrylamide gel electrophoresis patterns produced by Clostridium difficile. Rev Infect Dis (1984) 1.56
Application of a technique for serogrouping Clostridium difficile in an outbreak of antibiotic-associated diarrhoea. J Infect (1986) 1.15
Clostridium difficile: the epidemiology and prevention of hospital-acquired infection. Infection (1982) 1.07
Molecular epidemiology of bacterial infections. Clin Lab Med (1985) 0.96
[Postantibiotic pseudomembranous colitis and related forms of diarrhea following use of antibiotics. II. Microbiological aspects]. Ned Tijdschr Geneeskd (1979) 0.86
[Is pseudomembranous colitis contagious?]. Ned Tijdschr Geneeskd (1986) 0.85
[Clostridium difficile and antibiotic-associated colitis in risk patients: 2-month epidemiologic study in an intensive care unit]. Klin Wochenschr (1983) 0.84
Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med (2009) 8.30
Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology (1988) 8.27
Meningitis caused by Streptococcus suis in humans. Rev Infect Dis (1988) 5.84
Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol (1986) 5.15
Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet (1995) 5.14
Once versus thrice daily gentamicin in patients with serious infections. Lancet (1993) 4.92
The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev (2010) 4.48
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect (2014) 3.33
Analysis of eight cases of neonatal meningitis and sepsis due to Enterobacter sakazakii. J Clin Microbiol (1983) 2.96
Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet (1986) 2.76
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect (2009) 2.69
Characteristics of major outer membrane proteins of Haemophilus influenzae. J Bacteriol (1983) 2.66
Molecular epidemiology of Legionella pneumophila serogroup 1. J Clin Microbiol (1984) 2.60
Clostridial toxin in faeces of healthy infants. Lancet (1978) 2.58
[New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin]. Ned Tijdschr Geneeskd (2004) 2.55
Homogeneity of cell envelope protein subtypes, lipopolysaccharide serotypes, and biotypes among Haemophilus influenzae type b from patients with meningitis in The Netherlands. J Infect Dis (1983) 2.51
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect (2009) 2.44
Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups. Lancet (1989) 2.39
Immunochemical characterization of Neisseria meningitidis serotype antigens by immunodiffusion and SDS-polyacrylamide gel electrophoresis immunoperoxidase techniques and the distribution of serotypes among cases and carriers. J Gen Microbiol (1980) 2.32
Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol (2008) 2.17
Phenotypic characterization and DNA relatedness in human fecal isolates of Aeromonas spp. J Clin Microbiol (1989) 2.09
Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01
Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis (2007) 1.97
Clones of serogroup B Neisseria meningitidis causing systemic disease in The Netherlands, 1958-1986. J Infect Dis (1990) 1.96
Identification of HLA-B27M1 and -M2 cross-reactive antigens in Klebsiella, Shigella and Yersinia. Immunology (1984) 1.89
Variability of low-molecular-weight, heat-modifiable outer membrane proteins of Neisseria meningitidis. Infect Immun (1980) 1.85
Fusobacterium nucleatum septicemia and portal vein thrombosis. Clin Infect Dis (1999) 1.83
Clostridium difficile: a European perspective. J Infect (2012) 1.81
Prevalence of Campylobacter-associated diarrhea among patients infected with human immunodeficiency virus. Clin Infect Dis (1997) 1.80
A study of 280 cases of neonatal meningitis in The Netherlands. J Infect (1984) 1.79
Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect Immun (1989) 1.74
Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis (1990) 1.69
Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005. Clin Microbiol Infect (2007) 1.66
Changes in outer membrane proteins of nontypable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J Infect Dis (1988) 1.59
Immunogenicity of meningococcal antigens as detected in patient sera. Infect Immun (1983) 1.58
Real-time PCR assay using fine-needle aspirates and tissue biopsy specimens for rapid diagnosis of mycobacterial lymphadenitis in children. J Clin Microbiol (2004) 1.57
Inherited complement deficiency in children surviving fulminant meningococcal septic shock. Eur J Pediatr (1995) 1.53
Clostridium difficile infection in the community: a zoonotic disease? Clin Microbiol Infect (2012) 1.52
Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. J Infect Dis (1988) 1.52
Comparison of two matrix-assisted laser desorption ionisation-time of flight mass spectrometry methods for the identification of clinically relevant anaerobic bacteria. Clin Microbiol Infect (2011) 1.51
Carrier rate of Streptococcus suis capsular type 2 in palatine tonsils of slaughtered pigs. J Clin Microbiol (1984) 1.49
Latex agglutination, counterimmunoelectrophoresis, and protein A co-agglutination in diagnosis of bacterial meningitis. J Clin Pathol (1978) 1.49
Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother (1994) 1.48
[Diarrhea due to Clostridium difficile toxin in hemato-oncological patients]. Ned Tijdschr Geneeskd (2001) 1.39
Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology (1994) 1.35
Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J Infect Dis (1990) 1.35
Rapid diagnosis of toxinogenic Clostridium difficile in faecal samples with internally controlled real-time PCR. Clin Microbiol Infect (2006) 1.34
Application of multiple-locus variable-number tandem-repeat analysis to determine clonal spread of toxin A-negative Clostridium difficile in a general hospital in Buenos Aires, Argentina. Clin Microbiol Infect (2009) 1.34
Clinical and microbiological evaluation of 46 episodes of genital ulceration. Genitourin Med (1987) 1.32
Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis (1999) 1.30
Release of tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect Immun (1995) 1.30
Use of highly discriminatory fingerprinting to analyze clusters of Clostridium difficile infection cases due to epidemic ribotype 027 strains. J Clin Microbiol (2008) 1.30
The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated. J Clin Microbiol (2001) 1.27
Colony variants of Neisseria meningitidis strain 2996 (B:2b:P1.2): influence of class-5 outer membrane proteins and lipopolysaccharides. J Med Microbiol (1985) 1.27
Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect (2009) 1.27
The interaction between Neisseria gonorrhoeae and the human cornea in organ culture. An electron microscopic study. Graefes Arch Clin Exp Ophthalmol (1988) 1.26
Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria. Clin Infect Dis (1994) 1.24
Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients. Br J Cancer (2010) 1.24
Relatedness of human and animal Clostridium difficile PCR ribotype 078 isolates determined on the basis of multilocus variable-number tandem-repeat analysis and tetracycline resistance. J Clin Microbiol (2010) 1.23
First isolation of Clostridium difficile 027 in Japan. Euro Surveill (2007) 1.23
The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa. J Infect Dis (1990) 1.22
Characteristics of Haemophilus ducreyi in culture. J Clin Microbiol (1984) 1.22
Struggling with recurrent Clostridium difficile infections: is donor faeces the solution? Euro Surveill (2009) 1.20
Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. Euro Surveill (2009) 1.18
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. Ned Tijdschr Geneeskd (2008) 1.18
Typing of Aeromonas strains by DNA restriction endonuclease analysis and polyacrylamide gel electrophoresis of cell envelopes. J Clin Microbiol (1989) 1.17
Antibiotic-induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis (1995) 1.16
Rapid diagnosis of Legionnaires' disease using an immunochromatographic assay for Legionella pneumophila serogroup 1 antigen in urine during an outbreak in the Netherlands. J Clin Microbiol (2000) 1.16
Comparison of strains of Legionella pneumophila serogroup 1 isolated in four Amsterdam hospitals from patients and hot-water supplies. J Infect Dis (1984) 1.15
The erythrocyte and epithelial cell receptors for Haemophilus influenzae are expressed independently. Infect Immun (1987) 1.15
[Epidemiology of Clostridium difficile PCR ribotype 027 in the Netherlands 2005-present and the emergence of other subtypes]. Ned Tijdschr Geneeskd (2008) 1.14
Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum. Am Rev Respir Dis (1990) 1.13
Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis (2012) 1.12
Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin Microbiol Infect (2009) 1.12
Susceptibility and HLA-B27 in post-dysenteric arthropathies. Immunology (1985) 1.12
Fatal mucormycosis presenting as an appendiceal mass with metastatic spread to the liver during chemotherapy-induced granulocytopenia. Scand J Infect Dis (1990) 1.10
Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol (1994) 1.09
Inaccuracy of routine susceptibility tests for detection of erythromycin resistance of Campylobacter jejuni and Campylobacter coli. Clin Microbiol Infect (2010) 1.09
Multiple organ dysfunction syndrome induced by whole-body hyperthermia and polychemotherapy in a patient with disseminated leiomyosarcoma of the uterus. Intensive Care Med (1999) 1.09
Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect (2012) 1.09
Lymphadenitis in children is caused by Mycobacterium avium hominissuis and not related to 'bird tuberculosis'. Eur J Clin Microbiol Infect Dis (2008) 1.08
Clostridium difficile in Dutch animals: their presence, characteristics and similarities with human isolates. Clin Microbiol Infect (2011) 1.08
Relapse of Legionella longbeachae infection in an immunocompromised patient. Neth J Med (1996) 1.08
Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea. Neth J Med (2008) 1.08
Drug of choice for chancroid. Lancet (1983) 1.06
Dysfunctional properdin in a Dutch family with meningococcal disease. N Engl J Med (1988) 1.06
Distinct geographic distribution of subtypes of Haemophilus influenzae type b in Western Europe. J Infect Dis (1987) 1.06
Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol (1998) 1.05
Heterozygous and homozygous factor H deficiency states in a Dutch family. Clin Exp Immunol (1996) 1.05
Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med (1993) 1.04
Acquisition of Clostridium difficile by piglets. Vet Microbiol (2010) 1.03
Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection. J Clin Microbiol (2010) 1.03
Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83. Bull World Health Organ (1987) 1.01
Current application and future perspectives of molecular typing methods to study Clostridium difficile infections. Euro Surveill (2013) 1.01
Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis (2011) 1.00
Pneumonia involving Aspergillus and Rhizopus spp. after a near-drowning incident with subsequent Nocardia cyriacigeorgici and N. farcinica coinfection as a late complication. Eur J Clin Microbiol Infect Dis (2005) 1.00
Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. Euro Surveill (2014) 0.99
Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin Infect Dis (1998) 0.98